Hungary has become the first European country where the authorities have granted authorisation to the emergency use of US drugmaker Eli Lilly's Covid-19 antibody drug bamlanivimab, the Hungarian Ministry of Human Resources said on Wednesday.
As the state news agency MTI reports, the National Institute of Pharmacy and Nutrition (OGYEI) earlier this month approved the use of bamlanivimab for the treatment of patients with mild and moderate cases of Covid-19 who are at risk of developing more serious forms of the disease, the ministry said in a statement.
Top 5 Articles
Duna House Profit Climbs Nearly 70% in Q3 November 24, 2025 
'Recharge' Campaign Launched to Boost Domestic Tourism January 21, 2026 
Richter Earnings Slip as Financial Loss Weighs November 6, 2025 
Genius Automotive Hungarian Subsidiary's CEE Expansion November 2, 2025 
Asiana Airlines to Launch Direct Seoul-Budapest Flight October 31, 2025
